ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - aciclovir, quantity: 800 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; pregelatinised maize starch; magnesium stearate; colloidal anhydrous silica - arx-aciclovir tablets are indicated for use in adult patients for: (1) the treatment of first episode (primary or non-primary) genital herpes and the management of recurrent episodes of genital herpes in certain patients. (2) the treatment of acute attacks of herpes zoster (shingles) when the duration of rash is less than 72 hours. (3) the management of patients with advaned symptomatic hiv disease cd4 + counts < 150 x 10(6)/l). in accordance with details specified in the "indications" and the "dosage and administration" sections of the approved product information provided as attachment 1.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - aciclovir, quantity: 200 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; pregelatinised maize starch; magnesium stearate; colloidal anhydrous silica - arx-aciclovir tablets are indicated for use in adult patients for: (1) the treatment of first episode (primary or non-primary) genital herpes and the management of recurrent episodes of genital herpes in certain patients. (2) the treatment of acute attacks of herpes zoster (shingles) when the duration of rash is less than 72 hours. (3) the management of patients with advanced symptomatic hiv disease (cd4 + counts < 150 x 10(6)/l). in accordance with details specified in the "indications" and the "dosage and adminsitration" sections of the approved product information provided as attachment 1.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - bupropion hydrochloride, quantity: 150 mg - tablet, modified release - excipient ingredients: magnesium stearate; carnauba wax; cysteine hydrochloride; microcrystalline cellulose; hypromellose; titanium dioxide; macrogol 400; propylene glycol; purified water; isopropyl alcohol; iron oxide black - zyban sr tablets are indicated as a short-term adjunctive therapy for the treatment of nicotine dependence in those who are committed to quitting smoking, when used in conjunction with counselling for smoking cessation/abstinence.

तंज़ानिया - अंग्रेज़ी - Tanzania Medicinces & Medical Devices Authority

renata limited, bangladesh - desogestrel , ethinylestradiol - tablets - 0.15/0.03

तंज़ानिया - अंग्रेज़ी - Tanzania Medicinces & Medical Devices Authority

renata limited, bangladesh - levonorgestrel - oral tablet - 1.5 mg

तंज़ानिया - अंग्रेज़ी - Tanzania Medicinces & Medical Devices Authority

renata limited, bangladesh - sildenafil citrate - tablet, film-coated - 100 mg

केन्या - अंग्रेज़ी - Pharmacy and Poisons Board

renata limited plot#1 milk vita road section-vii mirpur - desogestrel bp and ethinylestradiol bp - tablet - 0.15 mg desogestrel and 0.03 mg ethinylestradiol/… - hormonal contraceptives: progestogens for

केन्या - अंग्रेज़ी - Pharmacy and Poisons Board

renata limited plot#1 milk vita road section-vii mirpur - levonorgestrel bp - tablet - levonorgestrel 0.75 mg - hormonal contraceptives: progestogens for

तंज़ानिया - अंग्रेज़ी - Tanzania Medicinces & Medical Devices Authority

renata ltd, bangladesh - levonorgestrel & ethinylestradiol - tablet, sugar coated - -

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - digoxin, quantity: 0.0625 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; magnesium stearate; povidone; indigo carmine; oxidised maize starch; rice starch - indications as at 26 july 2000 : congestive heart failure - lanoxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. lanoxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because lanoxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - lanoxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.